ABC Expands Drug Development Services

Analytical Bio-Chemistry Laboratories (ABC) has expanded its capabilities to include comprehensive support for large molecule development. To that end, John C. Anders, Ph.D., has been appointed to lead the lab and biotech team. He has assembled a team of biopharmaceutical experts, each with more than 18 years of experience in protein chemistry and chromatography. The biotech lab is housed at the company’s new, 90,000 sq.-ft. pharmaceutical development facility in Columbia, MO.

Dr. Anders has more than 24 years of experience in drug development from both the sponsor and CRO side of the industry. He has held several leadership positions building and leading advanced cGMP large molecule analytical labs, and has expertise in protein chemistry technologies and analytical methods.

“ABC Laboratories’ recent investment in expanded biomolecule development capabilities complements our company’s long history of ELISA, RIA and EIA experience and bioanalytical support. It also leverages ABC’s extensive analytical capabilities to provide our clients with more comprehensive support for both large and small molecules,” said John Bucksath, general manager and senior vice president of ABC’s Pharmaceutical Services division.

Click here to find out more about ABC Laboratories